NCT00733473View on ClinicalTrials.gov

Nebulized Budesonide for Children Who Are Hospitalized for Acute Wheezing

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

December 31, 2009

Study Completion Date

January 31, 2010

Conditions
AsthmaAcute Asthma
Interventions
DRUG

Budesonide 0.5 mg/ml nebules

Children will receive 1 mg nebulized budesonide 2 times a day up to 5 days

DRUG

% 0.9 Saline solution

Children will receive 2 ml of nebulized saline 2 times a day up to 5 days

Trial Locations (1)

06380

Kecioren Education and Training Hospital, Ankara

All Listed Sponsors
lead

Kecioren Education and Training Hospital

OTHER

NCT00733473 - Nebulized Budesonide for Children Who Are Hospitalized for Acute Wheezing | Biotech Hunter | Biotech Hunter